Our team of investigators has conducted over 100 clinical trials ranging from Phase I to Phase IV.
The physicians and nurse practitioners of Infectious Diseases Physicians, Inc. (IDP) are our investigative leaders and are directly affiliated with the CARE-ID organization. They work seamlessly with the staff to lead our clinical trial studies.
Together we have extensive experience working with both pharmaceutical and biotechnology companies and government agencies. Our involvement in clinical research has played a critical role in the development of novel antibiotic and antiviral treatments as well as vaccine development.
Following all regulatory and clinical practice guidelines, we strive to ensure the safety and comfort of our study volunteers while generating quality data and reliable results.
David A. Wheeler, MD, FACP, FIDSA
Dr. Wheeler is a board certified infectious diseases physician and a partner of Infectious Diseases Physicians, Inc. In addition to studying new HIV treatments, he and his colleagues at CARE-ID have helped study vaccines, antibiotics and treatment and prevention for covid-19. He received his medical degree from the University of Virginia in 1982 and completed his Internal Medicine Residency at the University of Colorado in 1985, and his infectious diseases fellowship at the University of Maryland in 1991. He is fluent in Spanish and spent four years as an internist in Puerto Rico as part of the National Health Services Corps. He has been in the private practice of infectious diseases care in Northern Virginia since 1996.
Dr. Wheeler is a fellow of the American College of Physicians (FACP), a fellow of the Infectious Diseases Society of American (FIDSA), and a professor of Medical Education at the University of Virginia INOVA Campus. He works in the hospital, office, and clinical research settings. Within the specialty of infectious diseases, he had a particular interest in the treatment of HIV and the development of new medication for treatment. He has been a leader in HIV treatment in the Washington metropolitan area for the least 30 years and, through his work at CARE ID has helped in the development of most of our current HIV medications.
Amma Appiah-Asantewaa, BS, MPP
Research Manager
Since joining CARE-ID in 2012, Amma has been an exceptional member of the team. Her dedication has delivered outstanding coordination for comprehensive study participant education, data collection, lab specimen processing, and regulatory documentation from study start-up to completion. She has been the lead coordinator for clinical trial processes involving HIV, hepatitis, clostridium difficile, vaccine trials, and COVID-19 vaccines and therapeutics.
Amma’s broad experience in clinical research began in 1996 in Ghana and was further extended as a result of her involvement with the National Cancer Institute (NCI) and breast cancer research. Her clinical trial experience led to a position as a patient navigator for the D.C. Cancer Consortium (Washington, D.C.) to assist patients requiring guidance through the healthcare system. Amma received her Bachelor of Science degree in Legon, Ghana and her Master’s in Public Policy from Pepperdine University School of Public Policy.